Kang Sujin, Kafetsouli Dimitra, Ford Jamie, Wong Janice, Bracoud Luc, Suhy Joyce, Giannakopoulou Parthenia, Udeh-Momoh Chi, Russ Tom C, Ritchie Craig, Alexopoulou Zoi, Salinas Cristian, Saad Ziad S, Novak Gerald, Robinson Oliver, Middleton Lefkos T
Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, Charing Cross Hospital, London, UK.
Directorate of Public Health, Imperial College NHS Healthcare Trust, Charing Cross Hospital Site, London, UK.
Alzheimers Dement. 2025 Aug;21(8):e70594. doi: 10.1002/alz.70594.
Cerebral microhemorrhages (CMHs) and superficial siderosis (SS) are relatively common side effects of anti-amyloid immunotherapies, termed amyloid-related imaging abnormalities (ARIA-H). They are also observed in treatment-naïve older adults. This study explored relationships with modifiable and non-modifiable risk factors.
This cross-sectional study included 1414 cognitively unimpaired, treatment-naïve individuals aged 60 to 85 years from the Cognitive Health in Ageing Register: Investigational, Observational and Trial Studies in Dementia Research (CHARIOT): Prospective Readiness cOhort (PRO) SubStudy. Relationships between CMHs/SS and cardiovascular risk factors, amyloid beta (Aβ) load, apolipoprotein E (APOE) ε4 status, educational attainment, and white matter hyperintensities were investigated using regression analyses and structural equation modeling.
CMHs were observed in 8.3% of participants and SS in 1.3%. Significant risk factors for CMHs included age and hypertension. Higher education attainment appeared to have a protective effect. Elevated amyloid is a risk factor, particularly when adjusting for APOE ε4 status in individuals aged 70 or younger.
Increasing age and hypertension are significant risk factors of CMHs. Higher educational attainment may offer a protective effect.
Of the 1414 participants from the CHARIOT-PRO SubStudy (CPSS), CMHs were present in 118 (8.3%), and SS was present in 18 (1.3%). Age and hypertension were identified as significant risk factors for CMHs, and the latter had a stronger association with the presence of CMHs among female participants. Having a bachelor's degree or higher was found to be protective. Elevated brain amyloid burden, particularly when adjusted for APOE ε4 carrier status, was identified as a risk factor in individuals aged 70 years and below.
脑微出血(CMHs)和脑表面铁沉积(SS)是抗淀粉样蛋白免疫疗法相对常见的副作用,称为淀粉样蛋白相关成像异常(ARIA-H)。在未经治疗的老年人中也观察到这些情况。本研究探讨了它们与可改变和不可改变的风险因素之间的关系。
这项横断面研究纳入了1414名来自老年认知健康登记册:痴呆症研究中的调查、观察和试验研究(CHARIOT):前瞻性准备队列(PRO)子研究的60至85岁认知未受损、未接受治疗的个体。使用回归分析和结构方程模型研究了CMHs/SS与心血管危险因素、淀粉样蛋白β(Aβ)负荷、载脂蛋白E(APOE)ε4状态、教育程度和白质高信号之间的关系。
8.3%的参与者出现CMHs,1.3%出现SS。CMHs的显著危险因素包括年龄和高血压。较高的教育程度似乎具有保护作用。淀粉样蛋白升高是一个危险因素,尤其是在70岁及以下个体中调整APOE ε4状态时。
年龄增长和高血压是CMHs的重要危险因素。较高的教育程度可能具有保护作用。
在CHARIOT-PRO子研究(CPSS)的1414名参与者中,118人(8.3%)存在CMHs,18人(1.3%)存在SS。年龄和高血压被确定为CMHs的重要危险因素,后者在女性参与者中与CMHs的存在关联更强。发现拥有学士学位或更高学历具有保护作用。脑淀粉样蛋白负担升高,尤其是在调整APOE ε4携带者状态时,被确定为70岁及以下个体的危险因素。